Skip to main content
Scott Schuetze, MD, Oncology, Ann Arbor, MI

Scott M Schuetze MD PhD

Hematologic Oncology, Sarcoma


Professor, Internal Medicine, University of Michigan Medical School

Join to View Full Profile
  • 1500 East Medical Center DrB1 floor Cancer Recp CAnn Arbor, MI 48109

  • Phone+1 734-647-8902

Dr. Schuetze is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1996 - 1999
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1993 - 1996
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 1993

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2004 - 2026
  • NC State Medical License
    NC State Medical License 1993 - 1999
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors  
    Erin F Cobain, Francis Worden, Scott M Schuetze, Mark M Zalupski, Vaibhav Sahai, Ajjai Alva, Anne F Schott, Moshe Talpaz, JAMA Oncology
  • Efficacy and Tolerability of Trabectedin in Elderly Patients with Sarcoma: Subgroup Analysis from a Phase 3, Randomized Controlled Study of Trabectedin or Dacarbazine ...  
    A Elias, M Milhem, S Patel, S M Schuetze, M L Hensley, Annals of Oncology

Press Mentions

  • AHA News: Cancers of the Heart Are Rare -- and Here's Why
    AHA News: Cancers of the Heart Are Rare -- and Here's WhyFebruary 25th, 2019
  • Liposarcoma, Rare Cancer That Took Rob Ford’s Life, Hard to Treat: Oncologist
    Liposarcoma, Rare Cancer That Took Rob Ford’s Life, Hard to Treat: OncologistMarch 22nd, 2016

Grant Support

  • Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatmentUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
  • Early Phase Clinical Cancer Prevention ConsortiumUNIVERSITY OF MICHIGAN AT ANN ARBOR2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: